These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10468195)

  • 1. Effect of the in vivo catalase inhibition on aminonucleoside nephrosis.
    Pedraza-Chaverri J; Granados-Silvestre MD; Medina-Campos ON; Hernández-Pando R
    Free Radic Biol Med; 1999 Aug; 27(3-4):245-53. PubMed ID: 10468195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms.
    Hattori T; Ito M; Suzuki Y
    Jpn J Pharmacol; 1991 Aug; 56(4):465-73. PubMed ID: 1744988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis.
    Ginevri F; Gusmano R; Oleggini R; Acerbo S; Bertelli R; Perfumo F; Cercignani G; Allegrini S; D'Allegri F; Ghiggeri G
    Clin Sci (Lond); 1990 Mar; 78(3):283-93. PubMed ID: 2156648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy.
    Gwinner W; Landmesser U; Brandes RP; Kubat B; Plasger J; Eberhard O; Koch KM; Olbricht CJ
    J Am Soc Nephrol; 1997 Nov; 8(11):1722-31. PubMed ID: 9355075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I; Nakamura T; Tomino Y; Koide H
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats.
    Someya T; Kaneko K; Yamada T; Yamashiro Y
    Pediatr Nephrol; 2005 Oct; 20(10):1430-4. PubMed ID: 16079985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puromycin aminonucleoside inhibits mesangial cell-induced contraction of collagen gels by stimulating production of reactive oxygen species.
    Zent R; Ailenberg M; Waddell TK; Downey GP; Silverman M
    Kidney Int; 1995 Mar; 47(3):811-7. PubMed ID: 7752581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis.
    Huang S; Schaefer RM; Reisch S; Paczek L; Schaefer L; Teschner M; Sebekova K; Heidland A
    Kidney Blood Press Res; 1999; 22(3):121-7. PubMed ID: 10394110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
    Kojima K; Matsui K; Nagase M
    Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Garlic ameliorates hyperlipidemia in chronic aminonucleoside nephrosis.
    Pedraza-Chaverrí J; Medina-Campos ON; Granados-Silvestre MA; Maldonado PD; Olivares-Corichi IM; Hernández-Pando R
    Mol Cell Biochem; 2000 Aug; 211(1-2):69-77. PubMed ID: 11055549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole and dilazep suppress oxygen radicals in puromycin aminonucleoside nephrosis rats.
    Nakamura K; Kojima K; Arai T; Shirai M; Usutani S; Akimoto H; Masaoka H; Nagase M; Yamamoto M
    Eur J Clin Invest; 1998 Nov; 28(11):877-83. PubMed ID: 9824428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
    Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
    Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ; Wilke WL; Fettman MJ
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo detection of intrinsic reactive oxygen species using acyl-protected hydroxylamine in puromycin nephrosis.
    Ueda A; Hirayama A; Nagase S; Inoue M; Oteki T; Aoyama M; Yokoyama H
    Free Radic Res; 2007 Jul; 41(7):823-8. PubMed ID: 17577743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD; Bertram JF; Ryan GB
    Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin B and L in nephron segments of rats with puromycin aminonucleoside nephrosis.
    Olbricht CJ; Cannon JK; Tisher CC
    Kidney Int; 1987 Sep; 32(3):354-61. PubMed ID: 3669494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of lipid peroxidation in puromycin aminonucleoside-induced nephropathy.
    Fawcett JP; Jiang R; Walker RJ
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):227-34. PubMed ID: 7881871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.